Atlas Trials

Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer

Clinical trial NCT00006101 · COMPLETED

Trial details

NCT number
NCT00006101
Sponsor
Thomas E. Ahlering
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
1998-10-01
Primary completion
2012-12-01
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.